Showing results (11-20 of 22) with videos related to
Sort By:
Pageof 3
JMIR Cardio|September 13, 2024
A co-design case study of the development of heart failure e-TIPS to support self-managementCaleb Ferguson, Scott William, Sabine M Allida, et al.JMIR Cardio|November 7, 2024
The Development of Heart Failure Electronic-Message Driven Tips to Support Self-Management: Co-Design Case StudyCaleb Ferguson, Scott William, Sabine M Allida, et al.Spine Deformity|May 5, 2019
Quantifying Anterior Chest Wall Deformity in Adolescent Idiopathic Scoliosis: Correlation With Other Deformity Measures and Effects of Anterior Thoracoscopic Scoliosis SurgeryJ P Little, T J Loch-Wilkinson, A Sundberg, et al.Bioorganic & Medicinal Chemistry Letters|February 24, 2001
The 5-HT3 antagonist tropisetron (ICS 205-930) is a potent and selective alpha7 nicotinic receptor partial agonistJ E Macor, D Gurley, T Lanthorn, et al.Breast Cancer Research : BCR|May 28, 2024
Elevated expression of wildtype RhoC promotes ErbB2- and Pik3ca-induced mammary tumor formationNandini Raghuram, E Idil Temel, Toshihiro Kawamata, et al.Cancer Research|February 18, 2011
Cooperation between Pik3ca and p53 mutations in mouse mammary tumor formationJessica R Adams, Keli Xu, Jeff C Liu, et al.Stem Cell Reports|September 13, 2016
Identification of RSK and TTK as Modulators of Blood Vessel Morphogenesis Using an Embryonic Stem Cell-Based Vascular Differentiation AssayLamis Hammoud, Jessica R Adams, Amanda J Loch, et al.Journal of Medicinal Chemistry|November 7, 2000
(-)-Spiro[1-azabicyclo[2.2.2]octane-3,5'-oxazolidin-2'-one], a conformationally restricted analogue of acetylcholine, is a highly selective full agonist at the alpha 7 nicotinic acetylcholine receptorG Mullen, J Napier, M Balestra, et al.Cancer Research|September 25, 2015
Ras Signaling Is a Key Determinant for Metastatic Dissemination and Poor Survival of Luminal Breast Cancer PatientsKatherine L Wright, Jessica R Adams, Jeff C Liu, et al.Cancer Cell|May 26, 2012
Lunatic fringe deficiency cooperates with the Met/Caveolin gene amplicon to induce basal-like breast cancerKeli Xu, Jerry Usary, Philaretos C Kousis, et al.Pageof 3